Skip to main content

Considerations: Imaging in Prostate Cancer

  • Chapter
Imaging in Oncological Urology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Loch T. Urologic imaging for localized prostate cancer 2007. World J Urol. 2007;25:121.

    Article  PubMed  Google Scholar 

  2. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007;243:28.

    Article  PubMed  Google Scholar 

  3. Wijkstra H, Wink MH, de la Rosette JJ. Contrast specific imaging in the detection and localization of prostate cancer. World J Urol. 2004;22:346.

    Article  PubMed  Google Scholar 

  4. Halpern EJ. Contrast-enhanced ultrasound imaging of prostate cancer. Rev Urol. 2006;8 Suppl 1:S29.

    Google Scholar 

  5. Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol. 2005;173:1926.

    Article  PubMed  Google Scholar 

  6. Remzi M, Dobrovits M, Reissigl A, Ravery V, Waldert M, Wiunig C, et al. European Society for Oncological Urology (ESOU): Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol. 2004;46:451.

    PubMed  Google Scholar 

  7. Cheng S, Rifkin MD. Color Doppler imaging of the prostate: important adjunct to endorectal ultrasound of the prostate in the diagnosis of prostate cancer. Ultrasound Q. 2001;17:185.

    Article  PubMed  CAS  Google Scholar 

  8. Drudi FM, Giovagnorio F, Carbone A, Ricci P, Petta S, Cantisani V, et al. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy–comparison with MRI. Ultraschall Med. 2006;27:146.

    Article  PubMed  CAS  Google Scholar 

  9. Tamsel S, Killi R, Apaydin E, Hekimgil M, Demirpolat G. The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy. Clin Radiol. 2006;61:325.

    Article  PubMed  CAS  Google Scholar 

  10. Yi A, Kim JK, Park SH, Kim KW, Kim HS, Kim JH, et al. Contrast-enhanced sonography for prostate cancer detection in patients with indeterminate clinical findings. AJR. 2006;186:1431.

    Article  PubMed  Google Scholar 

  11. Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer. 2005;104:2373.

    Article  PubMed  Google Scholar 

  12. Yves EP, Gomella LG, Halpern EJ. Effect of dutasteride therapy on Doppler evaluation of the prostate: preliminary results. Radiology. 2005;237:197.

    Article  Google Scholar 

  13. Frey H. Realtime elastography. A new ultrasound procedure for the reconstruction of tissue elasticity. Radiologe. 2003;43(10):850–5.

    Google Scholar 

  14. König K, Scheipers U, Pesavento A, Lorenz A, Ermert H, Senge T. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol. 2005;174(1):115–7.

    Article  PubMed  Google Scholar 

  15. Cochlin DL, Ganatra RH, Griffiths DF. Elastography in the detection of prostatic cancer. Clin Radiol. 2002;57(11):1014–20.

    Article  PubMed  Google Scholar 

  16. Cruz M, Tsuda K, Narumi Y, et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol. 2002;12:357–65.

    Article  PubMed  CAS  Google Scholar 

  17. Kirkham APS, Emberton M, Allen C. How good is MRI at detection and characterising cancer within the prostate? Eur Urol. 2006;50:1163–7.

    Article  PubMed  Google Scholar 

  18. Qayyum A, Cookley FV, Lu Y, et al. Organ confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004;183:1079–83.

    PubMed  Google Scholar 

  19. Schlemmer HP, Merkle J, Grobholz R, et al. Can preoperative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol. 2004;14:309–14.

    Article  PubMed  Google Scholar 

  20. Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol. 2003;76:617–24.

    Article  PubMed  CAS  Google Scholar 

  21. Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate. 2005;62:40–7.

    Article  Google Scholar 

  22. Ikonen S, Karkkainen P, Kivisaari L, et al. Magnetic resonance imaging of clinically localized prostate cancer. J Urol. 1998;159:915–9.

    Article  PubMed  CAS  Google Scholar 

  23. Vilanova JC, Barceló J. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging. Abdom Imaging. 2007; (Epub ahead of print).

    Google Scholar 

  24. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging – clinicopathologic study. Radiology. 1999;213:473–80.

    PubMed  CAS  Google Scholar 

  25. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of prostate biopsy, magnetic resonance imaging, and magnetic resonance spectrocopic imaging with step section histology. J Urol. 2000;164:400–4.

    Article  PubMed  CAS  Google Scholar 

  26. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005;234:804–14.

    Article  PubMed  Google Scholar 

  27. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging. 2002;16:451–63.

    Article  PubMed  Google Scholar 

  28. Sala E, Akin O, Moskowitz CS, et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology. 2006;238:929–37.

    Article  PubMed  Google Scholar 

  29. Cornud F, Flam T, Chauveinc L, et al. Extraprostatic spread of clinically localized prostate cancer : factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology. 2002;224:203–10.

    Article  PubMed  Google Scholar 

  30. Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardina PT. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology. 2004;232:140–6.

    Article  PubMed  Google Scholar 

  31. Wolf JS JR, Cher M, Dall’era M, Presti JC, Hricak H,Carroll PR. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol. 1995;153:993–9.

    Google Scholar 

  32. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, et al. EAU guidelines on prostate cancer. Eur Urol. 2005;48:546–51.

    Google Scholar 

  33. Saokar A, Braschi M, Harinsinghani MG. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging. Abdom Imaging. 2006;31:660–7.

    Article  PubMed  CAS  Google Scholar 

  34. Bellin MF, Roy C, Kinkel K, et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles – initial clinical experience. Radiology. 1998;207:799–808.

    PubMed  CAS  Google Scholar 

  35. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph node metastasis in prostate cancer. N Engl J Med. 2003;348:2491–9.

    Article  PubMed  Google Scholar 

  36. Heidenreich A, Varga Z, v Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastases. J Urol.2002;167:1681–6.

    Google Scholar 

  37. Bader P, Burkhardt FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol. 2002;168:514–8.

    Article  PubMed  Google Scholar 

  38. Wawroschek F, Vogt H, Wengenmair H, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int. 2003;70:303–10.

    Article  PubMed  Google Scholar 

  39. Palmer E, Henrikson K, McKusik K, Strauss HW, Hochberg F. Pain as an indicator of bone metastasis. Acta Radiol. 1988;29:445–9.

    Article  PubMed  CAS  Google Scholar 

  40. Tombal B, Rezazadeh A, Therasse P, van Cangh PJ, Vande Berg B, Lecouvet FE. Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases. Prostate. 2005;65:178–87.

    Google Scholar 

  41. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high risk prostate cancer: 99m Tc-MDP planar bone scintigraphy, single-and multi field of view SPECT, 18F-flouride PET, and 18F-flouride PET/CT. J Nucl Med. 2006;47:287–97.

    PubMed  Google Scholar 

  42. Delpassand ES, Garcia JR, Bhadkamar V, Podoloff DA. Value of SPECT imaging of the thoracolumbar spine in cancer patients. Clin Nucl Med. 1995;20:1047–51.

    Article  PubMed  CAS  Google Scholar 

  43. Dehdashti F, Picus J, Michalski JM, et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging. 2005;32:344–50.

    Article  PubMed  Google Scholar 

  44. Parent EE, Dence CS, Sharp TL, et al. Synthesis and biological evaluation of a flourine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]flouro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide. Nucl Med Biol. 2006;33:615–24.

    Article  PubMed  CAS  Google Scholar 

  45. Lee KC, Sud S, Meyer CR, et al. An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res. 2007;67:3524–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Heidenreich, A. (2009). Considerations: Imaging in Prostate Cancer. In: de la Rosette, J.J., Manyak, M.J., Harisinghani, M.G., Wijkstra, H. (eds) Imaging in Oncological Urology. Springer, London. https://doi.org/10.1007/978-1-84628-759-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-759-6_24

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-514-1

  • Online ISBN: 978-1-84628-759-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics